Antimicrobial protein activity

"Antimicrobial protein activity" refers to the functional ability of proteins and peptides to directly kill or inhibit the growth of microbial pathogens, including bacteria, fungi, viruses, and sometimes parasites. This activity is most commonly exerted by antimicrobial peptides (AMPs)—small, often cationic, amphipathic polypeptides produced by virtually all living organisms as a critical component of the innate immune response[1][2][8]. AMPs target microbial cell membranes or intracellular structures by diverse mechanisms—typically resulting in rapid cell death. Unlike conventional antibiotics, they often display a broad spectrum of activity and reduced risk of cross-resistance. Many are being explored or used as therapeutic agents, usually for severe or resistant infections, and a few have additional immunomodulatory or anti-tumor activities. Due to the generality of the term, "antimicrobial protein activity" does not correspond to a single canonical molecular target, abbreviation, or drug interaction profile[1][2][5][8].\n\n**Summary**: "Antimicrobial protein activity" is a descriptive term, not a therapeutic target. It should be replaced with a specific peptide/protein name (e.g., "Defensin", "Cathelicidin", "LL-37"), to extract structured target information[1][2][8].

Other names

Antimicrobial activity of peptidesHost defense peptide activityAntimicrobial peptides (when referring to the molecules mediating this activity)

Membrane disruption: many antimicrobial peptides disrupt microbial membranes or form pores; Interference with intracellular processes: some peptides penetrate the cell and inhibit DNA, RNA, or protein synthesis; Immunomodulation: some act to enhance or dampen host immune responses; Anti-biofilm activity: interference with biofilm formation or disruption of established biofilms